45 artykułów
Growth hormone is well established in general endocrinology as having an anti-insulin, or „insulin-antagonistic", effect on the body. This means that CJC-1295 and ipamorelin – both…
Currently, there are no human clinical trials demonstrating that CJC-1295, ipamorelin, or their combination improve joint recovery, tendon repair, or injury healing. The few...
Water retention and numbness or tingling in the hands are well-recognised effects of elevated growth hormone in general medicine, with a documented mechanism behind them. Specific clinical trials…
IGF-1, a hormone that CJC-1295 and ipamorelin increase, has a real and well-documented role in hair follicle biology. This comes from general dermatological research. No study…
No peer-reviewed human study specifically measuring CJC-1295 administered as a nasal spray has been identified in the scientific literature reviewed for this article. This means that despite...
CJC-1295 and ipamorelin raise IGF-1 indirectly. They do this by stimulating growth hormone release via two separate biological pathways. IGF-1 itself is what is produced later in the liver,…
CJC-1295 is not „forbidden" in the sense of being an illegal street drug. However, it is banned in professional sport under global anti-doping regulations. And it has never received approval…
General pharmaceutical guidelines for handling lyophilised peptides apply to CJC-1295. However, no independently published, peer-reviewed stability study specific to this compound has been…
No published human study has shown that CJC-1295 causes cancer. However, this is not the same as saying that the question has been thoroughly researched and ruled out.
There is no peer-reviewed reconstitution protocol specific to CJC-1295 or ipamorelin in the clinical literature. Nor is there a validated ratio of bacteriostatic water, vial shelf-life schedule, or comparison...
This article will not provide step-by-step mixing instructions, reconstitution ratios, or a personal administration protocol for CJC-1295 or ipamorelin. These are unapproved compounds. Neither of them…
No published human study on CJC-1295 or ipamorelin has specifically tested administration on an empty stomach compared to administration after a meal. The common advice to take these…
There is no clinically established „cycle length" for CJC-1295 or ipamorelin, and this article does not provide a recommended number of weeks or months for using these compounds. This is because...
Polish Polish 
English (United States)
French
German
Swedish
Italian
Spanish
Czech
Slovak
Indonesian
Hungarian
Romanian
Portuguese
Bulgarian
Lithuanian
Latvian
Slovenian
Danish
Finnish
Estonian
Dutch
English (UK)
Arabic
Japanese
Korean
